Syndrome of body fat redistribution in HIV-1-infected patients: Relationships to cortisol and catecholamines

Clinical Endocrinology

Volumn 51, Issue 2, 1999, Pages 223-230

  Renard, Eric ^a   Fabre, Jacqueline ^b   Paris, Françoise ^a   Reynes, Jacques ^b   Bringer, Jacques ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; ESTRADIOL; HYDROCORTISONE; TESTOSTERONE; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ARTICLE; BODY FAT; BODY MASS; CALORIMETRY; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CONTROL; ESTRADIOL BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; IMPEDANCE; LIPODYSTROPHY; LIPOLYSIS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; THYROID HORMONE BLOOD LEVEL; URINE VOLUME;

ADIPOSE TISSUE; ADULT; BODY CONSTITUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; CATECHOLAMINES; ELECTRIC IMPEDANCE; ENERGY METABOLISM; HIV INFECTIONS; HUMANS; HYDROCORTISONE; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 0032798685     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00777.x     Document Type: Article

References (36)

1. Bamberger, C.M., Schulte, H.M. & Chrousos, G.P. (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Reviews, 17, 245-261.
2. Behrens, G., Schmidt, H., Meyer, D., Stoll, M. & Schmidt, R.E. (1998) Vascular complications associated with use of HIV protease inhibitors (letter). Lancet, 351, 1958.
3. Bouchard, C., Després, J.P. & Mauriège, P. (1993) Genetic and nongenetic determinants of regional fat distribution. Endocrine Reviews, 14, 72-93.
4. Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D.J. & Cooper, D.A. (1998a) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 12, F51-F58.
5. Carr, A., Samaras, K., Chisholm, D.J. & Cooper, D.A. (1998b) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet, 351, 1881-1883.
6. Chrousos, G.P. & Gold, P.W. (1998) A healthy body in a healthy mind-and vire versa-The damaging power of 'uncontrollable' stress (editorial). Journal of Clinical Endocrinology and Metabolism, 83, 1842-1845.
7. Grinspoon, S.A. & Bilezikian, J.P. (1992) HIV disease and the endocrine system. New England Journal of Medicine, 327, 1360-1365.
8. Grunfeld, C. & Feingold, K.R. (1992) Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. New England Journal of Medicine, 327, 329-337.
9. Harris, J. & Benedict, F. (1919) A biometric study of basal metabolism in man. Publication 279, pp. 40-44. Carnegie Institution, Washington DC.
10. Hellerstein, M.K., Grunfeld, C., Wu, K., Christiansen, M., Kaempfer, S., Kletke, C. & Shackleton, C.H.L. (1993) Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism, 76, 559-565.
11. Hengel, R.L., Watts, N.B. & Lennox, J.L. (1997) Benign symmetric lipomatosis associated with protease inhibitors. Lancet, 350, 1596.
12. Henry, K., Melroe, H., Huebsch, J., Hermundson, J., Levine, C., Swensen, L. & Daley, J. (1998) Severe premature coronary disease with protease inhibitors. Lancet, 351, 1328.
13. Herry, I., Bernard, L., de Truchis, P. & Perrone, C. (1997) Hypertrophy of the breasts in a patient treated with indinavir. Clinical Infectious Diseases, 25, 937-938.
14. Ho, T.T.Y., Chan, K.C.W., Wong, K.H. & Lee, S.S. (1998) Abnormal fat distribution and use of protease inhibitors (letter). Lancet, 351, 1736-1737.
15. Hommes, M.J.T., Romijn, J.A., Godfried, M.H., Eeftinck Schattenkerk, J.K.M., Buurman, W.A., Endert, E. & Sauerwein, H.P. (1990) Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism, 39, 1186-1190.
16. Kotler, P.J., Wang, J. & Pierson, R.N. (1985) Body composition studies in patients with the acquired immunodeficiency syndrome. American Journal of Clinical Nutrition, 42, 1255-1265.
17. Leenen, R., Van der Kooy, K., Seidell, J.C., Deurenberg, P. & Koppeschaar, H.P.F. (1994) Visceral fat accumulalion in relation to sex hormones in obese men and women undergoing weight loss therapy. Journal of Clinical Endocrinology and Metabolism, 78, 1515-1520.
18. Leibel, R.L., Edens, N.K. & Fried, S.K. (1989) Physiologic basis for the control of body fat distribution in humans. Annual Revue of Nutrition, 9, 417-443.
19. Lipsky, J.J. (1998) Abnormal fat accumulation in patients with HIV-1 infection (commentary). Lancet, 351, 847-848.
20. Lo, J.C., Mulligan, K., Tai, V.W., Algren, H. & Schambelan, M. (1998) 'Buffalo hump' in men with HIV-1 infection. Lancet, 351, 867-870.
21. Lortholary, O., Chrisleff, N., Casassus, P., Thobie, N., Veyssier, P., Trogoff, B., Torri, O., Brauner, M., Nunez, E.A. & Guillevin, L. (1996) Hypothalamo-pituitary-adrenal function in human immunodeficiency virus-infected men. Journal of Clinical Endocrinology and Metabolism, 81, 791-796.
22. Macallan, D.C., Noble, C., Baldwin, C., Jebb, S.A., Prentice, A.M., Coward, A., Sawyer, M.B., McManus, M.J. & Griffin, G.E. (1995) Energy expenditure and wasting in human immunodeficiency virus infection. New England Journal of Medicine, 333, 83-88.
23. Marin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S. & Björntorp, P. (1992) Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism, 41, 882-886.
24. Melchior, J.C., Salmon, D., Rigaud, D., Leport, C., Bouvet, E., Detruchis, P., Vildé, J.L., Vachon, F., Coulaud, J.P. & Apfelbaum, M. (1991) Resting energy expenditure is increased in stable, malnourished HIV-infected patients. American Journal of Clinical Nutrition, 53, 437-441.
25. Miller, K.D., Jones, E., Yanovski, J.A., Shankar, R., Feuerstein, I. & Falloon, J. (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet, 351, 871-875.
26. Norbiato, G., Bevilacqua, M., Vago, T., Baldi, G., Chebat, E., Bertora, P., Moroni, M., Galli, M. & Oldenburg, N. (1992) Cortisol resistance in acquired immunodeficiency syndrome. Journal of Clinical Endocrinology and Metabolism, 74, 608-613.
27. Ott, M., Lembcke, B., Fischer, H., Jäger, R., Polat, H., Geier, H., Rech, M., Staszewski, S., Helm, E.B. & Caspary, W.F. (1993) Early changes of body composition in human immunodeficiency virus-infected patients : tetrapolar body impedance analysis indicates significant malnutrition. American Journal of Clinical Nutrition, 57, 15-19.
28. Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J. & Holmberg, S.D. The HIV outpatient Study Investigators (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.
29. Presta, E., Leibel, R.L. & Hirsch, J. (1990) Regional changes in adrenergic receptor status during hypocaloric intake do not predict changes in adipocyte size or body shape. Metabolism, 39, 307-315.
30. Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes, 7, 1595-1607.
31. Rosmond, R., Dallman, M.F. & Björntorp, P. (1998) Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. Journal of Clinical Endocrinology and Metabolism, 83, 1853-1859.
32. Roza, A.M. & Schizgal, H.M. (1984) The Harris Benedict equation reevaluated : resting energy requirement and the body cell mass. American Journal of Clinical Nutrition, 40, 168-182.
33. Saint-Marc, T. & Touraine, J.L. (1998) 'Buffalo hump' in HIV-1 infection (letter). Lancet, 351, 319-320.
34. Samra, J.S., Clark, M.L., Humphreys, S.L., MacDonald, I.A., Bannister, P.A. & Frayn, K.N. (1998) Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. Journal of Clinical Endocrinology and Metabolism, 83, 626-631.
35. Sellmeyer, D.E. & Grunfeld, C. (1996) Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocrine Reviews, 17, 518-532.
36. Wurtz, R. (1998) Abnormal fat distribution and use of protease inhibitors (letter). Lancet, 351, 1735-1736.